期刊文献+

影响肝硬化患者预后的多因素分析 被引量:2

Main indexes for the prognosis of liver cirrhosis by COX regression
原文传递
导出
摘要 目的探讨影响肝硬化患者预后的主要指标。方法对1995年12月~2005年12月住院肝硬化患者278例进行回顾性分析。记录患者的血气、电解质、肝功能、Child-pugh分级等实验室资料。采用χ2和t检验和非参数检验进行单因素分析,COX回归进行多因素分析。结果单因素分析显示Child-pugh分级、氧分压、氧饱和度、谷丙转氨酶(ALT)、直接胆红素(DBIL)、间接胆红素(IBIL)等与肝硬化患者预后相关(P<0.05)。COX回归显示年龄OR为1.024(1.001~1.047)、pH值OR为0.493(0.213~1.138)、二氧化碳分压OR为0.402(0.218~0.741)、标准碳酸氢盐OR为1.194(1.033~1.380)、氧饱和度OR为0.973(0.954~0.993)、直接胆红素OR为1.004(1.001~1.007)为影响肝硬化患者预后的主要指标。结论影响肝硬化患者预后的指标为体内的酸碱平衡,如pH、二氧化碳分压、标准碳酸氢盐、氧饱和度;另外,肝功能指标直接胆红素也对预后有一定影响。 Objective To investigate the main indexes for the prognosis of liver cirrhosis. Methods Arterial blood gases, electrolytes, the severity of cirrhosis (including Child-pugh score) were measured in 278 patients with liver cirrhosis. SPSS was used for analysis. Results Child-pugh, PaQ, SaO2, ALT, DBIL and IBIL were significant with liver cirrhosis (P 〈 0.05) by x^2, t-test or nonparametric test. Furthermore, age, pH, PaO2, STHCO3, SaO2 and DBIL were significant with liver cirrhosis by COX regression. The OR were 1.024(1.001 - 1.047), 0.493(0. 213- 1. 138), 0.402(0.218-0. 741), 1. 194(1.033- 1.380), 0. 973 (0. 954 - 0. 993), 1. 004 ( 1. 001 - 1. 007 ) respectively. Conclusions Acid-based disorders are the main indexes for the prognosis of liver cirrhosis. Also, DBIL has some influence.
出处 《中华疾病控制杂志》 CAS 2009年第1期72-74,共3页 Chinese Journal of Disease Control & Prevention
关键词 肝硬化 危险因素 回归分析 Liver cirrhosis Risk factors Regression analysis
  • 相关文献

参考文献3

二级参考文献23

  • 1戴志澄 祁国明.中国病毒性肝炎血清流行病学调查(下卷)1992~1995[M].北京:科学技术文献出版社,1997,4..
  • 2俞顺章 刘佩莉 黄敬亨.启东县原发性肝癌于乙型肝炎表面抗原的关系[J].中华预防医学杂志,1986,20(1):70-70.
  • 3Castro M, Krowka MJ. Hepatopulmonary syndrome. A pulmonary vascular complication of liver disease. Clin Chest Med, 1996.17 : 35.
  • 4Krowka MJ.Dickson ER,cortese DA. Hepatopulmonary Syndrome.Clinical obserations and lack of therapeutic response to somatostatin analogue, chest, 1993,104 : 515 - 521.
  • 5KAMATH PS,WIESNER RH,MALINCHOC M,et al.A model to predict survival in patients with end-stage liver disease[J].Hepatology,2001,33(2):464-470.
  • 6GIANNINI E,BOTTA F,TESTA E,et al.The 1-year and 3-month prognostic utility of the AST/ALT ratio and model for end-stage liver disease score in patients with viral liver cirrhosis[J].Am J Gastroenterol,2002,97(11):2855-2860.
  • 7HABIB A,MIHAS AA,ABOU-ASSI SG,et al.High-density lipoprotein cholesterol as an indicator of liver function and prognosis in noncholestatic cirrhotics[J].Clin Gastroenterol Hepatol,2005,3(3):286-291.
  • 8RUF AE,KREMERS WK,CHAVEZ LL,et al.Addition of serum sodium into the MELD score predicts waiting list mortality better than MELD alone[J].Liver Transpl,2005,11(3):336-343.
  • 9HONG MH.Design Measurement Evaluation (the second edition)[M].Guangzhou:Zhong Shan University Publishing Company,2002:59.Chinese
  • 10ROBERT A,CHAZOUILLERES O.Prothrombin time in liver failure:time,ratio,activity percentage,or international normalized ratio[J].Hepatology,1996,24(6):1392-1394.

共引文献22

同被引文献28

  • 1Peng Ruan, Zuo-Jiong Gong and Quan-Rong Zhang Wuhan, China Department of Infectious Diseases, Renmin Hospital Wuhan University Medical College, Wuhan 430060 , China.Changes of plasma D(-) -lactate, diamine oxidase and endotoxin in patients with liver cirrhosis[J].Hepatobiliary & Pancreatic Diseases International,2004,3(1):58-61. 被引量:31
  • 2蔡元坤,秦新裕.D-乳酸与肠道屏障功能(文献综述)[J].国外医学(外科学分册),2004,31(6):331-335. 被引量:34
  • 3Tziomalos K, Athyros VG, Karagiannis A. Non-alcoholic fatty liv?er disease in type 2 diabetes- pathogenesis and treatment options[J]. CUff Vasc Pharmacol, 2012,10(2) :162-172.
  • 4Sherman KE. Alanine aminotransferase in clinical practice. A re?view[J]. Arch Intern Med, 1991,151 (2) :260-265.
  • 5Tiikkainen M, Bergholm R, Vehkavaara S, et al. Effects of iden?tical weight loss on body composition and features of insulin resist?ance in obese women witb bigh and low liver fat content[J]. Dia?betes, 2003,52 (3) : 701-707.
  • 6Nemesanszky E, LottJA. Ganuna-glutamyltransferase and its isoenzymes , progress and problems[J]. Clin Chern, 1985, 31 (6) :797-803.
  • 7WhitfieldJB. Gamma glutamyl transferase[J]. Crit Rev Clin Lab Sci, 2001,38(4) :263-355.
  • 8Yang W, LuJ, WengJ, et al. Prevalence of diahetes among men and women in China[J]. N EnglJ Med, 2010,362 (12) : 1090- 1101.
  • 9American Diahetes Association. Diagnosis and classification of dia?betes mellitus[J]. Diahetes Care, 2004 ,27 (Suppll ) : S5-SlO.
  • 10Alberti KG, Zimmet PZ. Definition, diagnosis and classification of diahetes mellitus and its complications. Part 1 : diagnosis and clas?sification of diahetes mellitusprovisional report of a WHO consulta?tion[J]. Diahet Med, 1998,15(7) :539-553.

引证文献2

二级引证文献34

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部